Clinical Trials Directory

Trials / Completed

CompletedNCT07138131

Impact of Omega 3 in Treatment of Inappropriate Sinus Tachycardia

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Benha University · Academic / Other
Sex
All
Age
12 Years – 16 Years
Healthy volunteers
Not accepted

Summary

This study aimed to evaluate the effect of omega-3 supplementation on heart rate (HR) control and heart rate variability (HRV) in children with inappropriate sinus tachycardia (IST).

Detailed description

Inappropriate sinus tachycardia (IST) is a is a common disease of the autonomic nervous system in children in which tachyarrhythmia characterized by a persistent increase in resting sinus rate or disproportionate elevation of heart rate (HR) with minimal physiological effort accompanied by wide ranging symptoms including palpitations, fatigue, presyncope, and exercise intolerance it could cause lead to total disability in severe cases .it also takes a chronic course with Significant adverse effects on quality of life.

Conditions

Interventions

TypeNameDescription
DRUGOmega 3Patients received omega-3 supplementation for 3 months.
OTHERStandard follow-upPatients received standard follow-up without treatment.

Timeline

Start date
2023-10-01
Primary completion
2024-09-01
Completion
2024-09-01
First posted
2025-08-22
Last updated
2025-08-22

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07138131. Inclusion in this directory is not an endorsement.